José Mariz

Central venous access in oncology: ESMO Clinical Practice Guidelines

Berta Sousa, Jenny Furlanetto, Margaret Hutka et al. · Annals of Oncology · 2015 · 187 citations · Full text

Medicine, Oncology, Surgery +13

Treatment patterns and outcomes of 2310 patients with secondary acute myeloid leukemia: a PETHEMA registry study

David Martínez‐Cuadrón, Juan Eduardo Megías‐Vericat, Josefina Serrano et al. · Blood Advances · 2021 · 65 citations · Full text

Medicine, Hematology, Oncology +17

Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 in comparison with rituximab in patients with previously untreated low-tumour-burden follicular lymphoma: a randomised, double-blind, parallel-group, phase 3 trial

Michinori Ogura, Juan‐Manuel Sancho, Seok‐Goo Cho et al. · The Lancet Haematology · 2018 · 63 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +5

SEPT2 is a new fusion partner of MLL in acute myeloid leukemia with t(2;11)(q37;q23)

Nuno Cerveira, Cecília Correia, Susana Bizarro et al. · Oncogene · 2006 · 52 citations

Medicine, Molecular Genetics, Oncology +11

Smoldering Multiple Myeloma (SMM) at High-Risk of Progression to Symptomatic Disease: A Phase III, Randomized, Multicenter Trial Based On Lenalidomide-Dexamethasone (Len-Dex) as Induction Therapy Followed by Maintenance Therapy with Len Alone Vs No Treatment

María‐Victoria Mateos, Lucía López‐Corral, Miguel‐Teodoro Hernández et al. · Blood · 2010 · 28 citations

Medicine, Hematology, Oncology +15